Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
1.55(c) 1.63(c) 1.7(c) 1.75(c) 1.6(c) Last
1 354 467 1 410 431 1 514 447 1 819 338 1 611 330 Volume
0.00% +5.16% +4.29% +2.94% -8.57% Change
More quotes
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease. The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
Sector
Biotechnology
Calendar
04/24Shareholder meeting
Surperformance© rating of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 21,0 M
EBIT 2014 -86,0 M
Net income 2014 -103 M
Debt 2014 39,3 M
Yield 2014 -
Sales 2015 30,2 M
EBIT 2015 -85,0 M
Net income 2015 -88,0 M
Finance 2015 86,1 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 44,8x
EV / Sales 2015 26,9x
Capitalization 899 M
More Financials
Latest news on LEXICON PHARMACEUTICALS, I
11h ago LEXICON PHARMACEUTICALS : LX4211 Achieves Positive Results In Type 1 Diabetes Cl..
04/14 LEXICON PHARMACEUTICALS : LXRX) Spikes on Diabetes Trial, Pulls Back Sharply
04/14 LEXICON PHARMACEUTICALS : LX4211 Achieves Positive Results In Type 1 Diabetes Cl..
04/10 LEXICON PHARMACEUTICALS : To Present At The 2014 Needham Healthcare Conference
04/08 LEXICON PHARMACEUTICALS : Morning Review on Top Gainers -- Research on Peregrine..
04/03 LEXICON PHARMACEUTICALS : To Present At The 2014 Needham Healthcare Conference
03/07 LEXICON PHARMACEUTICALS, INC. : LEXICON PHARMACEUTICALS, INC./DE - 10-K - Manage..
02/28 LEXICON PHARMACEUTICALS, INC. : Lexicon Pharmaceuticals Provides Clinical Pipeli..
02/28 LEXICON PHARMACEUTICALS, INC. : Lexicon Pharmaceuticals Assigned Patent
02/26 LEXICON PHARMACEUTICALS, INC. : Lexicon to Report Fourth Quarter and Year End 20..
02/24 LEXICON PHARMACEUTICALS, INC. : Lexicon Pharmaceuticals Assigned Patent
02/20 LEXICON PHARMACEUTICALS, INC. : Lexicon to Report Fourth Quarter and Year End 20..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
Lexicon Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Lexicon Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF